Dermatology Doctors in Macon, GA Accepting Medicare

11 Dermatology doctors found. Showing 1 - 11

Virginia Childs Hall, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 520 Charter Blvd, Suite 100, Macon, GA 31210 Phone: 478-477-6700    Fax: 478-757-8135

Dr. Judah Norman Greenberg, M.D. Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 308 Coliseum Dr Ste 200, Macon, GA 31217 Phone: 478-314-0784    Fax: 478-745-2623

David E Kent, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 308 Coliseum Dr, Suite 200, Macon, GA 31217 Phone: 478-742-2180    Fax: 478-745-2623

Billie Luke Jackson, M.D. Dermatology Medicare: May Accept Medicare Assignments Practice Location: 440 Charter Blvd, Suite 2201, Macon, GA 31210 Phone: 478-477-5575    Fax: 478-477-0707

Dr. Mitchell Schoen Herold, MD Dermatology Medicare: Medicare Enrolled Practice Location: 308 Coliseum Dr, Macon, GA 31217 Phone: 478-742-2180

David J Cohen, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 308 Coliseum Dr, Suite 200, Macon, GA 31217 Phone: 478-742-2180    Fax: 478-745-2623

Supriya Immaneni, MD Dermatology Medicare: Medicare Enrolled Practice Location: 308 Coliseum Dr, St 200, Macon, GA 31217 Phone: 478-742-2180

Bruce Stuart Allen, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1338 Old Forsyth Rd, Macon, GA 31210 Phone: 478-471-7788

Mark W Bonner, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1157 Forsyth St, Macon, GA 31201 Phone: 478-745-8581    Fax: 478-328-0438

John A Broyles, MD Dermatology - Pediatric Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1157 Forsyth St, Macon, GA 31201 Phone: 478-745-8581    Fax: 478-328-0438

Dr. Jennifer Hawkins Allen, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 520 Charter Blvd, Suite 100, Macon, GA 31210 Phone: 478-477-6700    Fax: 478-757-8135

News Archive

BioTrends publishes new LaunchTrends report on Actemra

BioTrends is pleased to announce the publication of a new syndicated report, LaunchTrends®: ACTEMRA. Actemra (tocilizumab), marketed by Roche-Genentech, is the first IL-6 receptor inhibitor agent approved for rheumatoid arthritis. This report is the first in a three wave series and is derived from on-line survey responses from 77 rheumatologists and qualitative interviews with 20 rheumatologists.

High-throughput analysis of blood plasma could help identify biomarkers for ALS

High-throughput analysis of blood plasma could aid in identification of diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis (ALS), according to research from North Carolina State University.

Colon cancer patients lacking CDX2 protein more likely to benefit from chemotherapy

Using a new computer science approach, researchers at University of California, San Diego School of Medicine, Columbia University and Stanford University discovered a distinctive molecular feature — a biomarker — that identified colon cancer patients who were most likely to remain disease-free up to five years after surgery.

Neurological Institute at University Hospitals receives Neuroscience Center of Excellence designation

The Neurological Institute at University Hospitals has been designated as a Neuroscience Center of Excellence (COE), according to the Neuroscience Center of Excellence Survey sponsored by NeuStrategy, Inc., Chicago. It is the first neurological program in Ohio to receive the Stage 4 - Institute designation.

Curemark awarded QTDP grant to advance development of CM-AT for autism

Curemark LLC, a drug research and development company focused on the treatment of neurological diseases, announced today that it has been awarded a grant by the United States government under the Qualifying Therapeutic Discovery Project (QTDP) Program to advance the development of its lead product CM-AT for autism. CM-AT is presently in Phase III clinical trials at 18 sites around the US.

Read more Medical News

› Verified 9 days ago